Authors: CARTY TJ SWEENEY FJ GRIFFITHS RJ ESKRA JD ERNEST MJ PILLAR JS CHENG JD LOOSE LD JOSEPH PA PAZOLES PP MOORE PF NAGAHISA A MURASE S KADIN SB

Citation: Tj. Carty et al., TENIDAP INHIBITS 5-LIPOXYGENASE PRODUCT FORMATION IN-VITRO, BUT THIS ACTIVITY IS NOT OBSERVED IN 3 ANIMAL-MODELS, Inflammation research, 46(5), 1997, pp. 168-179

Authors: MOORE PF LARSON DL OTTERNESS IG WEISSMAN A KADIN SB SWEENEY FJ ESKRA JD NAGAHISA A SAKAKIBARA M CARTY TJ

Citation: Pf. Moore et al., TENIDAP, A STRUCTURALLY NOVEL DRUG FOR THE TREATMENT OF ARTHRITIS - ANTIINFLAMMATORY AND ANALGESIC PROPERTIES, Inflammation research, 45(2), 1996, pp. 54-61

Authors: ANDREWS EG ANTOGNOLI GW BRESLOW R CARTA MP CARTY TJ CHAMBERS RJ CHENG JB COHAN VL COLLINS JL DAMON DB DELEHUNT J EGGLER JF ESKRA JD FREIERT KW HADA WA MARFAT A MASAMUNE H MELVIN LS MULARSKI CJ NACLERIO BA PAZOLES CJ PILLAR JS RAPPACH LA REICHE P RUSEK FW SHERMAN H SHIRLEY JT SWEENEY FJ TICKNER JE WATSON JW WRIGHT CF

Citation: Eg. Andrews et al., SYNTHESIS AND PHARMACOLOGICAL PROFILE OF 2 NOVEL HETEROCYCLIC CHROMANOLS, CP-80,798 AND CP-85,958, AS POTENT LTD(4) RECEPTOR ANTAGONISTS, Bioorganic & medicinal chemistry letters, 5(13), 1995, pp. 1365-1370